Evidence map›Paper›PMID 36369656›Full record

ArticleFEBS open bio2023

Halogenated boroxine increases propensity to apoptosis in leukemia (UT-7) but not non-tumor cells in vitro.

Maida Hadzic, Yitong Sun, Nikolina Tomic, Eirini Tsirvouli, Martin Kuiper, Lejla Pojskic

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in FEBS open bio, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. NewArhiv za higijenu rada i toksikologiju · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Maida HadzicInstitute for Genetic Engineering and Biotechnology, University of Sarajevo, Bosnia and Herzegovina.
Yitong SunInstitute for Biology, Norwegian University of Science and Technology, Trondheim, Norway.
Nikolina TomicInstitute for Genetic Engineering and Biotechnology, University of Sarajevo, Bosnia and Herzegovina.ORCID 0000-0001-9529-3384
Eirini TsirvouliInstitute for Biology, Norwegian University of Science and Technology, Trondheim, Norway.ORCID 0000-0002-6456-6463
Martin KuiperInstitute for Biology, Norwegian University of Science and Technology, Trondheim, Norway.ORCID 0000-0002-1171-9876
Lejla PojskicInstitute for Genetic Engineering and Biotechnology, University of Sarajevo, Bosnia and Herzegovina.ORCID 0000-0003-2260-318X
Norwegian University of Science and Technology · NOUniversity of Sarajevo · BA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A hallmark of the development of solid and hematological malignancies is the dysregulation of apoptosis, which leads to an imbalance between cell proliferation, cell survival and death. Halogenated boroxine [K

Indexed as

ApoptosisLeukemiaCell ProliferationHumansNF-kappa BSignal TransductionNF-kappa Banti-tumor propertiesapoptosisDEGshalogenated boroxineleukemiapathway enrichment analysis

Identifiers

PMID36369656
PMCPMC9811610
OpenAlexW4308835058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.